Skip to content

Ayurvedic management of joints pain

Role of Vedanahara Regimen over that of Conventional Medicine in the Management of Amavata W.S.R to Rheumatoid Arthritis-A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017740
Enrollment
60
Registered
2019-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: Vedanahara Regimen: Before starting the trial drugs, Panchkol Churn 3 gms twice daily with lukewarm water and Baluka /Saindhav lavan Swedan will be adviced for 10 days then from 11th da

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients having the clinical manifestation of Amavata given in ayurvedic classics and /or classification criteria for rheumatoid arthritis. -Patients willing to participate in the research study

Exclusion criteria

Exclusion criteria: -Patients with other systemic complications of RA,poorly controled Hypertension and Diabetes Mellitus. -Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis,psoriatic arthritis etc. -Patients unable to walk without support or confined to wheel chair. -Patients on prolonged medication with corticosteroid, anti-depressants,anti-cholinergic etc -Patients having past history of atrial fibrillation,acute coronary syndrome, myocardial infarction,stroke,severe arrhythmia in the last 6 months. -Patients with serious hepatic disorders, serious renal disorders,severe pulmonary dysfunction etc. -Patients having more than 10 yrs of history of duration of diagnosed Amavata. -Alcoholics and drug abusers -Pregnant and lactating woman -Patients who have completed participation in any other clinical trial during the past 6 months.

Design outcomes

Primary

MeasureTime frame
Relief in the Cardinal sign and symptoms of Amavata(RA),providing the Vedanahara (analgesic)effect and management of Amavata(RA) with Vedanahara regimenTimepoint: 70 days

Secondary

MeasureTime frame
Improvement in the quality of life with the help of questionnaire for scaling of WHO quality of life, Significant decrease in value (quantitative)of ESR,RA factors,CRP,and Gradual increase in Hb% valueTimepoint: 70 days

Countries

India

Contacts

Public ContactDr Raja Ram Mahto

All India Institute of Ayurveda

drrky68@gmail.com9412148437

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026